Possible anaphylactic reaction to abciximab

Catheterization and Cardiovascular Interventions

Volumn 48, Issue 1, 1999, Pages 71-73

  Guzzo, Joseph A ^a   Nichols, Timothy C ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Adverse reaction; Angioplasty; Integrin; Platelet glycoprotein IIb IIIa inhibitor; Stenting

Indexed keywords

ABCIXIMAB; ADRENALIN; ATROPINE; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; METHYLPREDNISOLONE SODIUM SUCCINATE; MORPHINE; STEROID;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; CASE REPORT; CORONARY STENT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; UNSTABLE ANGINA PECTORIS;

ANAPHYLAXIS; ANGINA, UNSTABLE; ANTIBODIES, MONOCLONAL; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; STENTS;

EID: 0032869230     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199909)48:1<71::AID-CCD14>3.0.CO;2-2     Document Type: Article

References (12)

1. EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
2. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696.
3. Food and Drug Administration. Important Prescribing Information Letter-Rituxan. Rockville, MD: MedWatch; 1998.
4. Sifton DW, Westly GJ, Pfohl B, editors. Physicians Desk Reference. Montvale, NJ: Medical Economics Data Production Company; 1996.
5. Harle DG, Baldo BA, Coroneos NJ, Fisher MM. Anaphylaxis following administration of papaveretum: case report - implication of IgE antibodies that react with morphine and codeine, and identification of an allergic determinant. Anesthesiology 1989;71: 489-494.
6. Austin KF. Disease of immediate type hypersensitivity. In: Isselbach KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrison's principles of internal medicine, 13th ed. New York: McGraw Hill; 1994. p 1630-1638.
7. Lieberman P, Siegle RL, Taylor WW. Anaphylactoid reactions to iodinated contrast material. J Allergy Clin Immunol 1978;62:174-180.
8. Cogen FC, Norman ME, Dunsky E, Hirshfeld J, Zweiman B. Histamine release and complement changes following injection of contrast media in humans. J Allergy Clin Immunol 1979;64:299-303.
9. Cohen SA. Abciximab and alveolar hemorrhage. N Engl J Med 1998;339:1362.
10. Food and Drug Administration. Points to Consider in the Manufacturing and Testing of Monoclonal Antibody Products for Humans. Rockville, MD: Center for Biologics Evaluation and Research, Dockets Management Branch (HFA-305); 1997.
11. Food and Drug Administration. Supervisory Overview of BLA 97-0200. Rockville, MD: Center for Biologics Evaluation and Research; 1997.
12. Food and Drug Administration. Medical Officer's Review: The EPIC trial 3-year data. Rockville, MD: Center for Biologics Evaluation and Research; 1998.